ReviewInterventional cardiology (London, England)2026
Sex Differences in Imaging for Structural Heart Disease: What is Normal for Women?
Review in Interventional cardiology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring Gender Disparities and Advances in Transcatheter Structural Heart Interventions.Interventional cardiology (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The accessibility of advanced imaging techniques has led to the exponential growth of transcatheter valve and structural interventions. The prevalence of valve disease in women is increasing in both developed and developing countries. Despite this increase in disease burden in women, optimal imaging indices for referral are understudied and underused in both research and clinical settings, resulting in later referral for intervention, suboptimal risk prediction and arbitrary procedural and device selection. Available published clinical trials are deficient in adequate sex-specific enrolment, resulting in a paucity of evidence to guide refined valve-related management in female patients. Thus, data referenced in current guidelines scarcely outline sex-specific recommendations with reference to optimal selection criteria, timing for referral and optimal procedural strategy and follow-up for this group of patients. This review summarises the available literature, focusing on disparities in imaging in women with valvular heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.